Showing results (1381-1390 of 1,599) with videos related to

Sort By:
Pageof 160
Journal for Immunotherapy of Cancer|January 4, 2025
Effect of radiotherapy exposure on fruquintinib plus sintilimab treatment in refractory microsatellite stable metastatic colorectal cancer: a prospective observation studyMingxia Cheng, Min Jin, Shengli Yang, et al.
Cell Death and Differentiation|April 3, 2026
Multiple pathways of CD34+ cell differentiation during embryogenesisTing Wang, Hui Gong, Guoguo Ye, et al.
Oncogenesis|May 15, 2021
LMW cyclin E and its novel catalytic partner CDK5 are therapeutic targets and prognostic biomarkers in salivary gland cancersAmriti R Lulla, Said Akli, Cansu Karakas, et al.
Genomics & Informatics|October 30, 2012
Interaction Effects of Lipoprotein Lipase Polymorphisms with Lifestyle on Lipid Levels in a Korean Population: A Cross-sectional StudyJung-A Pyun, Sunshin Kim, Kyungchae Park, et al.
Experimental Cell Research|June 15, 2014
Induction of galectin-1 by TGF-β1 accelerates fibrosis through enhancing nuclear retention of Smad2Min Jin Lim, Jiyeon Ahn, Jae Youn Yi, et al.
Eukaryotic Cell|September 15, 2009
Reconstruction of signaling networks regulating fungal morphogenesis by transcriptomicsVera Meyer, Mark Arentshorst, Simon J Flitter, et al.
Cancer Genetics and Cytogenetics|December 16, 2010
FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literatureMin Jin Kim, Sun Young Cho, Myeong-Hee Kim, et al.
International Journal of Endocrinology and Metabolism|August 25, 2017
Chylothorax Associated with Substernal Goiter in Graves' Disease Treated with Radioactive IodineSeo Young Oh, Bo Hyun Kim, Do Young Kim, et al.
Cancer Cell International|January 30, 2014
Correlation between HER-2/neu(erbB-2) expression level and therapeutic effect of combination treatment with HERCEPTIN and chemotherapeutic agents in gastric cancer cell linesHai Cui, Ying Cheng, Su-Zhou Piao, et al.
The Oncologist|July 11, 2024
Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II studyMin Jin, Hong-Li Liu, Jun Xue, et al.
Pageof 160